As with the other multi-peptide bundles on this site, no clinical trial has tested these four compounds together — the rationale is theoretical, combining four individually-studied (to very different degrees — see each page) mechanisms rather than a validated combined effect. GHK-Cu and KPV have the thinnest human evidence of the four (see their pages); BPC-157 has three small human pilots; TB-500's human data is entirely for a different, related molecule (full-length Thymosin Beta-4).
Yes — same four-peptide combination (GHK-Cu, BPC-157, TB-500, KPV) already covered in depth under the generic bundle FAQ. Specific to this branded version: dosing runs 10mg/10mg/50mg/10mg — TB-500 sits notably higher than the other three components.
Looking for something specific, or placing a wholesale order? Send us a DM or email.